NSE:BMLL

BIO MEDICA LABORATORIES L

₹154.90
at close · 27 Oct 2026
▲ 8.90 (+6.10%)

Latest filings

  1. Quarterly corporate governance report not applicable to SME-listed company · Compliance
  2. All five insider-information events recorded in September quarter · Compliance
  3. RTA certificate: no physical share certificates received for demat in Sep 2026 quarter · Compliance
All filings ↓
Ask Nexa about BIO MEDICA LABORATORIES L

Snapshot

What the business is, and whether it's a good one at a fair price.

A listed company listed on NSE.

Charts

How has the market priced it — with filings on the timeline?

BMLL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from BIO MEDICA LABORATORIES L's filed financials and exchange disclosures

What does BIO MEDICA LABORATORIES L do?

BIO MEDICA LABORATORIES L is listed on NSE, trading under the symbol BMLL.

How much does the BIO MEDICA LABORATORIES L share price move in a day?

On a typical session BIO MEDICA LABORATORIES L moves 1.90% — that is the median absolute close-to-close move across its last 97 trading days. MarketPing measures each filing's price reaction against it.

Where can I track BIO MEDICA LABORATORIES L's announcements?

Every NSE and BSE filing by BIO MEDICA LABORATORIES L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.